featured
Alcohol companies lobby Congress on cannabis drinks (Newsletter: October 22, 2025)
Published
2 days agoon
NJ governor candidates on marijuana; OH cannabis & hemp bill advances; PA cannabis regulatory vote; Non-cannabis CBD developed from kitchen spice
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
New House and Senate lobbying reports show that alcohol companies and industry groups are stepping up lobbying efforts around hemp drinks—also detailing how major businesses like DoorDash and PayPal are engaged in cannabis-related congressional advocacy.
As New Jersey voters prepare to elect a new governor, the candidates have contrasting marijuana views—with Republican Jack Ciattarelli calling cannabis a “gateway drug” and Democrat Mikie Sherrill voting for and sponsoring reform legislation in Congress.
The Ohio House Judiciary Committee approved a bill to revise the state’s voter-approved marijuana legalization law by removing some protections for consumers and to restrict intoxicating hemp products.
The Pennsylvania Senate Law & Justice Committee approved a bill to create a Cannabis Control Board to oversee the existing medical marijuana program and intoxicating hemp products—and which could also regulate the adult-use market if broader legalization is enacted.
Researchers behind a new federally funded study developed a new class of CBD-like compounds using the common kitchen spice caraway seeds—not cannabis—that “not only prevented seizures and reduced seizure-related deaths but also promoted healthier brain cell development.”
The Rhode Island Cannabis Control Commission approved a timeline for issuing new marijuana dispensary licenses, including to social equity applicants and worker-owned cooperatives.
/ FEDERAL
The White House has paused the nomination process for President Donald Trump’s nomination to be a federal judge in Florida amid his involvement in an ongoing investigation into the alleged misuse of Medicaid funds to campaign against a marijuana legalization initiative on the state’s 2024 ballot.
The U.S. Senate Caucus on International Narcotics Control held a hearing on Hezbollah’s ties to drug trafficking.
Sen. Rand Paul (R-KY) said that the Trump administration’s military strikes against alleged drug boats “go against all our tradition.”
House Armed Services Committee Ranking Member Adam Smith (D-WA) is calling for a hearing on the Trump administration’s military attacks on suspected drug boats.
/ STATES
Rhode Island Gov. Dan McKee (D) announced that the state’s top cannabis regulator is concluding her tenure.
A caller to Nebraska Gov. Jim Pillen’s (R) radio show was hung up on in the middle of making a point about medical cannabis legislation.
Ohio’s Senate president and House minority leader discussed the prospects for passing hemp legislation.
The Maryland House Ways and Means Committee toured a cannabis processing facility.
A Florida senator hosted a cannabis forum.
A former Delaware judge authored an op-ed about the “risks” of marijuana legalization.
Louisiana regulators adopted changes to medical cannabis rules.
Illinois regulators held a hearing on proposed changes to cannabis rules.
Oklahoma regulators are delaying the launch of a new medical cannabis portal.
Vermont regulators sent a reminder about new hemp product labeling requirements.
Utah regulators sent various updates about the medical cannabis program.
Minnesota regulators will host an information session about cannabis community restoration grants on Thursday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.![]()
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
San Francisco, California’s mayor said President Donald Trump’s threats to send the National Guard to the city “will do nothing to get fentanyl off the streets or make our city safer.”
A former Fall River, Massachusetts mayor was stabbed near the marijuana dispensary he serves as CEO for.
/ INTERNATIONAL
Brazil’s agrarian development minister pressured Meta to reinstate banned cannabis-related Instagram accounts.
Ten parties running in Netherlands elections support legalizing cannabis.
/ SCIENCE & HEALTH
A review concluded that “cannabinoids are promising therapeutic targets in the treatment of sepsis, as they improved survival, and reduced inflammation and organ injury.”
A study found that “in a state [medical cannabis] program, barriers related to MC access and cost indicated a significant increase in the likelihood of [illicit medical cannabis] use.”
/ BUSINESS
Organigram Global Inc.s’ outgoing CEO will stay on longer as the company completes an ongoing search for a replacement.
Charlotte’s Web Holdings, Inc. has a new board of directors member.
/ CULTURE
Musician Jelly Roll picked a team in a college football game based on marijuana, saying that “if this came down to the battle of the growers, I’m riding in Michigan, baby… My favorite place to partake in recreational activity in America.”
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
SCOTUS cannabis & guns case gets delay request (Newsletter: October 24, 2025)
-
Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’
-
What To Know About Cannabis And A Brain Aneurysm
-
MariMed to Expand Brand Distribution to New York
-
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
-
Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More
featured
SCOTUS cannabis & guns case gets delay request (Newsletter: October 24, 2025)
Published
28 minutes agoon
October 24, 2025
Whiskey company cites marijuana in scaling back biz; OH psychedelics grant; Study: Cannabis tied to reduced alcohol liver disease
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on.
Check us out on Patreon and sign up to give $25/month today:
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Trump administration Solicitor General D. John Sauer submitted a request for a delayed timeline to file briefs in a marijuana and gun rights case that the Supreme Court is taking up—with the respondent’s lawyers agreeing to the extension.
The Ohio Department of Behavioral Health is supporting a program to educate first responders, police and healthcare professionals about how to deal with adverse psychedelic experiences with a $400,000 grant.
Whiskey company Heritage Distilling is scaling back its operations, citing “consumer shifts toward reduced alcohol consumption and alternative products, including marijuana.”
A new study found that marijuana use is “associated with a reduced risk of [alcohol-associated liver disease], with the greatest risk reduction seen in patients with” so-called “cannabis use disorder.”
- “Cannabis use was linked to lower risks of ALD, liver-related complications and death compared to non-cannabis users.”
NORML activist Chris Goldstein argues in a new Marijuana Moment op-ed that New Jersey gubernatorial candidates in next month’s election “barely seem to be paying attention” to issues of concern for cannabis consumers.
West Virginia officials are refusing to allocate $34 million in medical cannabis revenue that is supposed to support drug treatment, research and law enforcement programs over concerns about federal prohibition.
- “The money in the fund will remain unallocated until federal law changes.”
/ FEDERAL
Rep. Brittany Pettersen (D-CO) inserted remarks into the Congressional Record congratulating an attorney for being named “lawyer of the year” and noting that he “helped create regulations for recreational marijuana.”
/ STATES
Minnesota Gov. Tim Walz (D) signed another cannabis compact with a tribe.
The Kentucky legislature’s Interim Joint Committee on Health Services held a hearing on the rollout of the state’s medical cannabis program.
A Wisconsin senator said he’s optimistic a medical cannabis legalization bill will pass the Senate.
Rhode Island’s former top marijuana regulator announced she is running for attorney general.
Washington, D.C. regulators adopted changes to medical cannabis rules.
The New Mexico Medical Cannabis Advisory Board will meet on Monday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.![]()
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
New York City mayoral candidates weighed in on safe consumption sites for illegal drugs during a debate.
/ INTERNATIONAL
Zurich, Switzerland officials are moving to extend a legal cannabis sales pilot project.
/ SCIENCE & HEALTH
A study highlighted the “potential of [unsaponifiable matter from hemp seed] as a natural anti-obesity therapeutic, offering new avenues for the treatment and prevention of obesity and related metabolic disorders.”
A study found that “MDMA increases feelings of trust in the social world.”
/ BUSINESS
Emerald Intel acquired Cannabiz Media.
IM Cannabis Corp. signed a non-binding indicative term sheet to acquire a 60 percent equity interest in a quantum computing bio data company.
Circle K plans to begin selling hemp-derived THC drinks nationwide in 2026.
Village Farms International, Inc. launched a one-way aroma valve built directly into its cannabis flower packaging.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis/Side Pocket Images.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’
Published
10 hours agoon
October 23, 2025
Ohio House lawmakers passed the 18th version of a bill on Oct. 22 that aims to alter the state’s adult-use cannabis laws that voters approved in 2023, while also creating a tightly defined regulatory framework for hemp products.
The 228-page legislation, Substitute Senate Bill 56, preserves many aspects of the voter-approved initiative, such as home grows (six per adult or 12 per household), sharing between adults 21 and older, and allocating 36% of cannabis excise tax revenues to local municipalities that host dispensaries.
However, the bill would prohibit public consumption at places like music concerts and bar patios, and those caught with cannabis purchased outside the state would be criminalized. No other state where cannabis is legal imposes such restrictions on out-of-state purchases, according to cannabis advocacy group NORML.
In addition, while adults could continue to home cultivate cannabis under the legislation, they’d be restricted to harvesting more than 2.5 ounces of flower, or roughly one plant, with a felony penalty for those who grow more than the number of plants allowed. Also, the bill intends to place a 35% THC cap on flower and a 70% THC cap on extracts for both medical and adult-use cannabis.
“This isn’t what Ohioans voted for, and the fact that this bill is being rushed through the Legislature, with almost no opportunity for public comment, indicates that lawmakers know they are undermining the will of the voters,” NORML Political Director Morgan Fox said in a public statement. “Regardless of where one stands on cannabis issues, everyone should be outraged at this.”
The substitute bill found bipartisan House support in an 87-8 vote on Oct. 22.
Rep. Brian Stewart, R-Ashville, who carried Sub. S.B. 56 in the House, said Wednesday on the chamber floor that the bill “preserves all of the core aspects” of what voters passed two years ago, including access to tested and regulated products from licensed dispensaries.
Stewart also argued that the Legislature has to act to preserve the 36% tax revenue fund for host communities after the Ohio Department of Taxation flagged language in the voter-approved initiative, suggesting that the language failed to properly appropriate the money.
“It was always going to require legislation in this chamber,” he said.
The substitute bill also intends to establish a legal pathway for licensed “hemp dispensaries” to sell regulated and tested intoxicating hemp products, defined as containing more than 0.5 milligrams of delta-9 THC per serving or 2 milligrams per package, or more than 0.5 milligrams of total non-delta-9 THC per package. These sales would be limited to those 21 and older. Those who sell intoxicating hemp products to those under 21 would be guilty of a misdemeanor on the first offense and a felony on a subsequent offense.
Meanwhile, cannabinoid hemp beverages would be defined and regulated differently with a $1.20-per-gallon excise tax (more on this later).
Stewart said provisions included in the 18th version of the substitute bill resulted from a “Venn diagram from hell” that attempted to balance individual liberties, consumer safety, the financial well-being of local communities, and the “need to protect the health and safety” of Ohio children.
“If you’re reading through it and you’re saying, ‘Rep. Stewart, I don’t like Section X, I don’t like Section Y,’ please know you’re in good company. I don’t either,” he said. “This is not the bill that I originally introduced. It’s not the bill that Representative [Tex] Fischer originally introduced. But it is a carefully crafted compromise that makes Ohio better.”
While the Senate passed its version of the legislation in February, cannabis advocacy groups like the Marijuana Policy Project applauded the House Judiciary Committee for sitting on the legislation for nearly eight months as a means to prevent recriminalization measures “pushed by the Senate.”
However, many House members said during this week’s floor debate that Gov. Mike DeWine’s executive order issued Oct. 8 – one that attempts to shut down hemp-derived cannabinoid product sales and initiate emergency rulemaking – spurred lawmakers to go back to the drawing board for a legislative fix.
DeWine showcased various intoxicating hemp products in packaging that mimicked popular candies, like Nerds, Sour Patch Kids and Gushers, during his Oct. 8 press conference.
After lawmakers were at an impasse, DeWine’s executive order represented a turning point on Sub. S.B. 56, Rep. Tex Fischer, R-Boardman, said before Wednesday’s floor vote.
“I think we all had an agreement that that was not the intent of the hemp legislation at the federal level or here in Ohio, but we did need to do something to protect kids from these products,” he said. “Some of these products are truly illicit and truly dangerous, and everybody, no matter how fervent of an activist on the hemp side of this issue you were, agreed something needed to be done.”
Legislative disagreements had revolved around Ohio businesses that would be negatively impacted by language in previous versions of the bill, Fischer said.
Under the House-passed substitute bill, places where children “walk freely,” like gas stations and grocery stores, would be prohibited from selling intoxicating hemp products, while certain intoxicating hemp retailers, such as a qualifying vape shop, would be “grandfathered in” for licensure.
For a retailer to qualify for a grandfathered-in hemp dispensary license, that retailer must have sold intoxicating hemp products on or before Aug. 30, and the store’s receipts from hemp and intoxicating hemp product sales must have exceeded 80% of its total gross receipts for either the past 12 months or the 2024 calendar year.
“What about those people that have poured their blood, sweat, tears, years of work, potentially millions of dollars into building a business living by the rules that we set out, whether they were adequate or not, they were not breaking the law,” Fischer said. “Those were the people that I was motivated to stand up for, and while this bill doesn’t do everything that I wanted or everything that others want, I believe we have arrived at a reasonable conclusion to allow those people to still stay in business, to grandfather them into this new regulatory regime.”
No one under the age of 21 would be allowed inside these hemp dispensaries, which would be prohibited from selling cigarettes, tobacco, and vape or electronic smoking products under the bill. No more than 400 hemp dispensaries would be allowed in the state, unless those grandfathered in exceed that number.
While the biennial license renewal fee for Ohio’s cannabis dispensaries is $70,000, the two-year renewal license fee for a grandfathered-in hemp dispensary would be $35,000 under Sub. S.B. 56.
Meanwhile, hemp beverages, which the substitute bill defines as “drinkable cannabinoid products,” would be regulated differently. In addition, these products would be classified as low-level DCPs (5 milligrams or less of total THC per serving) or high-level DCPs (5-10 milligrams of total THC per serving). Only one serving per container would be allowed.
Neither low-level nor high-level DCPs would constitute an “intoxicating hemp product,” with DCPs falling under a separate regulatory framework for manufacturers, distributors and retailers. Still, sales to those under 21 would be prohibited.
Ohio retailers with Class C liquor licenses, such as grocery stores that sell alcohol for carryout only, would be allowed to sell high-level DCPs. Meanwhile, Ohio retailers with licenses for on-site consumption, such as restaurants and bars, would be allowed to sell low-level DCPs.
While the substitute bill would allow DCP manufacturers to create higher-dose beverages that contain more than 10 milligrams of THC, they would be restricted to distributing and/or selling those products to out-of-state partners.
Fischer said there were a lot of wins “for us so-called ‘hemp-resentatives,’” in the substitute bill.
“Many of you heard from beverage manufacturers, bars, restaurants, retailers about how popular these products are, but there are also a lot of folks that weren’t yet comfortable stocking these products because of the regulatory uncertainty that is a result of our inability to previously come to an agreement here in Columbus,” he said. “I think this strikes the appropriate tone of a reasonable, fair and pro-business regulatory regime while still maintaining that these products and consumers should be safe.”
While it’s unclear if the Senate will agree to the House’s amended substitute bill or take the legislation to a conference committee for further debate – before possibly sending the bill to DeWine’s desk – the potential outcomes are significant for Ohio stakeholders: cannabis businesses, hemp businesses, consumers, patients and children.
Rep. Jamie Callender, R-Concord, a long-time advocate for cannabis reform in the Buckeye State, acknowledged the legislation “is not perfect” before voting to support the bill.
Callender said a “no” vote on the legislation represents allowing retailers to continue selling high-THC products to children walking home from schools with impunity.
“I imagine everybody in this room can find at least one thing they don’t like in the bill, one thing they think can be improved on,” he said. “You have my commitment. I’ll keep working with everyone to make it better, but I believe we have to act.”
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
What To Know About Cannabis And A Brain Aneurysm
Published
11 hours agoon
October 23, 2025
Discover what to know about cannabis and a brain aneurysm—risks, recovery, and medical cautions.
When celebrity Kim Kardashian recently revealed she was diagnosed with a small brain aneurysm—reportedly detected during a routine MRI and attributed by her doctors to stress—her disclosure sparked interest in a condition most people don’t know much about. A brain aneurysm is a bulging or ballooning blood vessel in the brain, which can be life-threatening if it ruptures. With growing interest around cannabis use—both medically and recreationally—it’s worth exploring what to know about cannabis and a brain aneurysm.
RELATED: The Science Behind Cannabis And Happiness
A brain aneurysm (sometimes called an intracranial aneurysm) occurs when a weakened area of a blood vessel in the brain bulges outward. If the aneurysm ruptures, it can lead to a major bleed called a subarachnoid hemorrhage—a medical emergency. Many aneurysms remain small and never rupture, but risk factors include high blood pressure, smoking, genetic predisposition, and possibly vascular stress. Kim Kardashian’s case underlines how even individuals with public profiles and access to healthcare can face this silent risk.

Cannabis—or more precisely its components such as cannabidiol (CBD) and tetrahydrocannabinol (THC)—has been studied for a variety of health issues. For some conditions like chronic pain, certain forms of epilepsy, or spasticity in multiple sclerosis, cannabinoids may offer symptomatic relief. There is emerging evidence medical marijuana can improve quality of life for some patients: reducing pain, improving sleep or mood, and even decreasing reliance on opioids in certain contexts.
In the broad sense, in jurisdictions across the U.S., many patients use it under medical supervision for conditions like migraine, nausea from chemotherapy, or chronic neuropathic pain. “Medical” use does not equate to “safe in all contexts”—especially when other serious medical issues are present.
When it comes to brain aneurysms—particularly after diagnosis or treatment—the research raises caution flags about cannabis use:
- Studies show people who have had an aneurysmal subarachnoid hemorrhage (a burst aneurysm), cannabis users had higher rates of delayed cerebral ischemia (DCI)—a serious complication which can lead to poor outcome. One large study found cannabis users had about a 2.7 times greater risk of DCI compared with non-users.
- Other studies link recreational cannabis use to a higher likelihood of having an aneurysm rupture in the first place—one estimate suggested about an 18 % increased risk.
- Research also suggests cannabis affects vascular tone, cerebral blood flow, mitochondrial function in brain cells, and may contribute to vasospasm (narrowing of blood vessels) or oxidative stress—mechanisms which are particularly concerning in someone with a vulnerable blood vessel wall.
- One review warned even for unruptured aneurysms, if cannabis is used, individuals should be aware they may face worse outcomes should rupture occur.
RELATED: Evidence About Burning Mouth Syndrome And Cannabinoids
If you or someone you know has been diagnosed with a brain aneurysm (ruptured or unruptured), here are some practical steps:
- Talk to your neurologist/neurosurgeon about cannabis use. The research suggests elevated risks in people with aneurysms who use cannabis.
- Avoid assuming “medical use = safe.” Even if you’re using cannabis under a physician’s care, an aneurysm changes the risk profile.
- Focus on established risk-reduction: control blood pressure, stop smoking, manage cholesterol, avoid stimulants. These traditional strategies remain foundational.
- If you have an untreated aneurysm and are considering cannabis for medical reasons, proceed with caution.Ask your medical team about the specific size, location, treatment plan of your aneurysm and whether there are recommended restrictions.
- After an aneurysm rupture or treatment, strongly consider abstaining or closely monitoring any cannabis use. The data indicate increased complication rates in this particular setting.
The public disclosure by Kim Kardashian highlights how common aneurysms may be, but it also reminds us the decision to use cannabis in a medical context should be made carefully. While cannabis offers genuine medical benefits for some conditions, when a brain aneurysm is in the picture—especially one which has ruptured or is being observed—caution is warranted. Speak with a neurologist familiar with cerebrovascular risk, weigh the benefits and the unique risks, and make an informed choice rather than assuming “legal = safe.”
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
SCOTUS cannabis & guns case gets delay request (Newsletter: October 24, 2025)
Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’
What To Know About Cannabis And A Brain Aneurysm
MariMed to Expand Brand Distribution to New York
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More
Curio Wellness Acquires 4 Greenlight Dispensaries in Missouri
The best places to be high in Seattle
Colombia’s Bold Offer to Trump: Legal Weed Exports for Peace
Trump DOJ Asks Supreme Court For Delayed Schedule In Case On Marijuana Users’ Gun Rights
Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative
Smart Cannabis: The AI Revolution No Operator Can Ignore
New Jersey Gubernatorial Candidates Need To Step Up For Cannabis Consumers (Op-Ed)
Millennials Are Spending Big on Luxury Travel
West Virginia Medical Marijuana Revenue Is Supposed To Support Drug Treatment Programs, But Sits Unspent As Officials Worry About Federal Prohibition
Frequent Marijuana Use Is Tied To Lower Risk Of Liver Disease From Alcohol, New Study Finds
Ohio bill to scale back cannabis legalization passed by House (Newsletter: October 23, 2025)
FDA Weighs Petition On ‘Significant Harm’ Of Marijuana Hair Testing Device’s Positive Results From Secondhand Smoke
Wisconsin Lawmakers Rally for Medical Cannabis Legalization in Committee Hearing
Massachusetts Campaign To Roll Back Marijuana Legalization Law Is ‘On Track’ To Make 2026 Ballot, Spokesperson Says
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
Ohio House Passes Bill To Remove Voter-Approved Marijuana Legalization Protections And Restrict Hemp Market
Sorting Robotics Becomes Cannabis Manufacturing’s First True Systems Integrator
Wisconsin Senators Hold Hearing On GOP Leader’s New Medical Marijuana Legalization Bill
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
5 best CBD creams of 2024 by Leafly
Recreational cannabis on ballot for third time in South Dakota
EU initiative begins bid to open access to psychedelic therapies
New Study Analyzes the Effects of THCV, CBD on Weight Loss
Free delta-9 gummies from Bay Smokes
5 best autoflower seed banks of 2024 by Leafly
Discover New York’s dankest cannabis brands [September 2024]
May 2024 Leafly HighLight: Pink Runtz strain
Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products
5 best THC drinks of 2024 by Leafly
Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT
6 best CBD gummies of 2024 by Leafly
Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man
Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News
5 best delta-9 THC gummies of 2024 by Leafly
The Daily Hit: October 2, 2024
Mississippi city official pleads guilty to selling fake CBD products
Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”
Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline
5 best THCA flower of 2024 by Leafly
6 best hemp pre-rolls of 2024 by Leafly
PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana
Trending
-
California Cannabis Updates1 year agoAlert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year agoConnecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list1 year ago5 best CBD creams of 2024 by Leafly
-
Business1 year agoRecreational cannabis on ballot for third time in South Dakota
-
Business1 year agoEU initiative begins bid to open access to psychedelic therapies
-
cbd1 year agoNew Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Bay Smokes1 year agoFree delta-9 gummies from Bay Smokes
-
autoflower seeds1 year ago5 best autoflower seed banks of 2024 by Leafly



